GetPortalImpactFactorByIdResp(projectId=1, id=773212312, cover=https://img.medsci.cn/20231103/1698992018544_1614372.jpg, fullname=Therapeutic Advances in Medical Oncology, abbr=THER ADV MED ONCOL, pyear=2009, frequence=Bimonthly, articleNumbers=912, citedSelf2015=0.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均5.14月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1758-8340, greenSci=https://www.greensci.net/search?kw=1758-8340, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-MED-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=8.7, medsciHotlight=11.099, medsciHotlight5year=7.60683, citescore=6.8, hIndex=49, impactFactor=4.9, orgnization=SAGE Publications Inc., orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index ExpandedClarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://journals.sagepub.com/home/TAM?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, websiteHits=8567, guideForAuthor=https://journals.sagepub.com/author-instructions/TAM?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, guideForAuthorHits=112, submitWebsite=https://journals.sagepub.com/home/TAM?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, submitWebsiteHits=4283, content=<p>该刊是经过同行评审的开放获取期刊，出版癌症医疗领域的前沿探索和创新研究。</p>, totalCites=4469, brief=THER ADV MED ONCOL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=THER ADV MED ONCOL在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=773212312'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=3), ImpactFactorTagDto(id=539, tagName=结直肠癌, createdHits=1), ImpactFactorTagDto(id=704, tagName=介入, createdHits=1), ImpactFactorTagDto(id=41133, tagName=肿瘤临床, createdHits=1), ImpactFactorTagDto(id=25209, tagName=回顾性研究, createdHits=1), ImpactFactorTagDto(id=8398, tagName=1, createdHits=1), ImpactFactorTagDto(id=17598, tagName=临床治疗, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.37), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.79), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.44), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.6), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=11.4), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=10.174), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=11.165), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=8.935), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=8.7)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=33/321)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1758-8340[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY[ta], article_number=158, article_number_cn=36, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)